³í¹®) Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks
¼¿ï´ëº´¿ø ¼øÈ¯±â³»°ú (»çÁø Á·κÎÅÍ) ±èÈ¿¼ö·¹Ú°æ¿ì·°ÁöÈÆ ±³¼ö(¾ç¼®ÈÆ ÀÓ»ó°»ç) ¿¬±¸ÆÀ